Biohacking Market to Surge to USD 85.78 Billion by 2032, Growing at a CAGR of 16.86%
The Biohacking Market was valued at USD 21.12 billion in 2023 and is projected to reach USD 85.78 billion by 2032, growing at a CAGR of 16.86% from 2024 to 2032. This rapid growth is fuelled by advancements in biotechnology, wearable health devices, nootropics, and genetic engineering, all of which empower individuals to enhance cognitive function, physical performance, and longevity through self-experimentation and human augmentation techniques.